Welcome to the Podiatry Arena forums, for communication between foot health professionals about podiatry and related topics.
You are currently viewing our podiatry forum as a guest which gives you limited access to view all podiatry discussions and access our other features. By joining our free global community of Podiatrists and other interested foot health care professionals you will have access to post podiatry topics (answer and ask questions), communicate privately with other members (PM), upload content, view attachments, receive a weekly email update of new discussions, earn CPD points and access many other special features. Registered users do not get displayed the advertisments in posted messages. Registration is fast, simple and absolutely free so please, join our global Podiatry community today!
If you have any problems with the registration process or your account login, please contact contact us.
Novo Nordisk Announces Upcoming Launch Of NovoPen Echo(TM), A Unique New Insulin Pen For Children With Diabetes
At the International Diabetes Federation World Diabetes Congress in Montreal, Canada, Novo Nordisk today presented its latest insulin pen specifically designed to meet the needs of children with diabetes. The NovoPen Echo? will be launched in several countries next year. It will be the first ever insulin pen to offer a combination of a memory function with a half-unit dosing option, which allows for very accurate dosing of insulin.